发明授权
- 专利标题： AKT nucleic acids, polypeptides, and uses thereof
- 专利标题（中）： AKT核酸，多肽及其用途
-
申请号： US12633984申请日： 2009-12-09
-
公开(公告)号： US07989584B2公开(公告)日： 2011-08-02
- 发明人: Kun Guo , Kenneth L. Clark , Yuri D. Ivashchenko , Marco Pagnoni
- 申请人： Kun Guo , Kenneth L. Clark , Yuri D. Ivashchenko , Marco Pagnoni
- 申请人地址： US NJ Bridgewater
- 专利权人： Aventis Pharmaceuticals Inc.
- 当前专利权人： Aventis Pharmaceuticals Inc.
- 当前专利权人地址： US NJ Bridgewater
- 主分类号： C07K14/17
- IPC分类号： C07K14/17 ; C07K19/00 ; C12N15/12
摘要：
The present invention relates to human Akt3 proteins and polypeptides. The invention also relates to isolated nucleic acids encoding human Akt3, to vectors containing them and to their therapeutic uses, in particular for gene therapy. Expression of Akt3 inhibits cell death associated with hypoxia, apoptosis or necrosis.
公开/授权文献
- US20100143308A1 AKT NUCLEIC ACIDS, POLYPEPTIDES, AND USES THEREOF 公开/授权日：2010-06-10
信息查询
